Association of Beta-Blocker Therapy With Risks of Adverse Cardiovascular Events and Deaths in Patients With Ischemic Heart Disease Undergoing Noncardiac Surgery: A Danish Nationwide Cohort Study

Study Questions:

What are associations of beta-blocker treatment with major adverse cardiovascular events (MACE) and all-cause mortality in patients with ischemic heart disease undergoing noncardiac surgery?